Tobira Therapeutics Taps Pharsight's PKS Online to Support HIV Drug Development

Tobira will use Pharsight's software to support the development of cenicriviroc, a drug candidate for the treatment of HIV.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.